Drug profile · INN
amantadine hydrochloride
AMANTADINE HYDROCHLORIDE
amantadine hydrochloride (AMANTADINE HYDROCHLORIDE) is a glutamate [nmda] receptor antagonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Drug details — amantadine hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.89
Quick answer
amantadine hydrochloride (AMANTADINE HYDROCHLORIDE) is a glutamate [nmda] receptor antagonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Glutamate [NMDA] receptor antagonist
Primary target: Glutamate [NMDA] receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is amantadine hydrochloride?
amantadine hydrochloride (AMANTADINE HYDROCHLORIDE) is a glutamate [nmda] receptor antagonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for amantadine hydrochloride?
AMANTADINE HYDROCHLORIDE is a marketed brand name for amantadine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of amantadine hydrochloride?
amantadine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.